TY - JOUR
T1 - Lupus anticoagulant, thrombosis and thrombocytopenia in systemic lupus erythematosus
AU - Averbuch, M.
AU - Koifman, B.
AU - Levo, Y.
PY - 1987
Y1 - 1987
N2 - Thirty-six patients were studied for the presence of the lupus anticoagulant and its possible clinical and laboratory associations. Seven patients were found to have the anticoagulant. These patients had a significantly increased incidence of both thromboembolic complications (5/7 vs. 2/29) and thrombocytopenia (4/7 vs 4/29). None of them had a bleeding tendency. Except for these associations, patients with the anticoagulant did not differ from those without the anticoagulant by any demographic, clinical, or laboratory parameter. The present study confirms observations that SLE patients with the lupus anticoagulant have an increased risk of thrombosis.
AB - Thirty-six patients were studied for the presence of the lupus anticoagulant and its possible clinical and laboratory associations. Seven patients were found to have the anticoagulant. These patients had a significantly increased incidence of both thromboembolic complications (5/7 vs. 2/29) and thrombocytopenia (4/7 vs 4/29). None of them had a bleeding tendency. Except for these associations, patients with the anticoagulant did not differ from those without the anticoagulant by any demographic, clinical, or laboratory parameter. The present study confirms observations that SLE patients with the lupus anticoagulant have an increased risk of thrombosis.
UR - http://www.scopus.com/inward/record.url?scp=0023124697&partnerID=8YFLogxK
U2 - 10.1097/00000441-198701000-00002
DO - 10.1097/00000441-198701000-00002
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 3101499
AN - SCOPUS:0023124697
VL - 293
SP - 2
EP - 5
JO - American Journal of the Medical Sciences
JF - American Journal of the Medical Sciences
SN - 0002-9629
IS - 1
ER -